These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18457222)

  • 1. Trials and tribulations.
    Gilbert S
    Hastings Cent Rep; 2008; 38(2):14-8. PubMed ID: 18457222
    [No Abstract]   [Full Text] [Related]  

  • 2. Extend the reach of institutional review boards first, then strengthen their depth.
    Spike J
    Am J Bioeth; 2008 Nov; 8(11):11-2. PubMed ID: 19061097
    [No Abstract]   [Full Text] [Related]  

  • 3. Medical ethics. Principles for human gene therapy studies.
    Friedmann T
    Science; 2000 Mar; 287(5461):2163-5. PubMed ID: 10744537
    [No Abstract]   [Full Text] [Related]  

  • 4. Duke's hazards. Did medical experiments put patients needlessly at risk?
    Kaplan S; Brownlee S
    US News World Rep; 1999 May; 126(20):66-8, 70. PubMed ID: 10387890
    [No Abstract]   [Full Text] [Related]  

  • 5. Legal and ethical issues associated with patient recruitment in clinical trials: the case of competitive enrolment.
    Caulfield T
    Health Law Rev; 2005; 13(2-3):58-61. PubMed ID: 16459415
    [No Abstract]   [Full Text] [Related]  

  • 6. Disclosing clinical trial results: publicity, significance and independence.
    Liao SM; Sheehan M; Clarke S
    Am J Bioeth; 2009 Aug; 9(8):W3-5. PubMed ID: 19998144
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioethical malpractice: risk and responsibilities in human research.
    Noah BA
    J Health Care Law Policy; 2004; 7(2):175-241. PubMed ID: 15573441
    [No Abstract]   [Full Text] [Related]  

  • 8. Federal drug agency gets flack about human subjects protections in clinical trials.
    Beckman M
    J Natl Cancer Inst; 2008 Jan; 100(2):90-1. PubMed ID: 18182612
    [No Abstract]   [Full Text] [Related]  

  • 9. Companies' use of web to recruit patients for studies brings opportunities, risks.
    Kuehn BM
    JAMA; 2008 Jun; 299(23):2733-4. PubMed ID: 18559993
    [No Abstract]   [Full Text] [Related]  

  • 10. Guinea-pigging.
    Elliott C
    Minn Med; 2008 Apr; 91(4):32-6. PubMed ID: 18549005
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulating the market in human research participants.
    Lemmens T; Miller PB
    PLoS Med; 2006 Aug; 3(8):e330. PubMed ID: 16866575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eight years after Jesse 's death, are human research subjects any safer?
    Gelsinger P; Shamoo AE
    Hastings Cent Rep; 2008; 38(2):25-7. PubMed ID: 18457225
    [No Abstract]   [Full Text] [Related]  

  • 13. Oversight mechanisms for clinical research.
    Snyderman R; Holmes EW
    Science; 2000 Jan; 287(5453):595-7. PubMed ID: 10691540
    [No Abstract]   [Full Text] [Related]  

  • 14. The concept of the IRB and bureaucratic reality: an exchange of letters.
    van Eys J; Levine RJ
    IRB; 1984; 6(4):8-10. PubMed ID: 11649563
    [No Abstract]   [Full Text] [Related]  

  • 15. Research involving children: regulations, review boards and reform.
    Gandhi R
    J Health Care Law Policy; 2005; 8(2):264-330. PubMed ID: 16471026
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical trials, pharmaceutical companies and clinical practice].
    Peralta V
    An Sist Sanit Navar; 2005; 28(1):7-16. PubMed ID: 15827575
    [No Abstract]   [Full Text] [Related]  

  • 17. Are new laws needed to protect human subjects?
    Zucker C
    Account Res; 2001; 8(3):235-44. PubMed ID: 12481767
    [No Abstract]   [Full Text] [Related]  

  • 18. Independent medical research.
    van der Meer JW; de Gier AM; van Swaaij WP; Katan MB
    Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759
    [No Abstract]   [Full Text] [Related]  

  • 19. Human research protections: time for regulatory reform?
    Maschke KJ
    Hastings Cent Rep; 2008; 38(2):19-22. PubMed ID: 18457223
    [No Abstract]   [Full Text] [Related]  

  • 20. Conflicts of interest in data monitoring of industry versus publicly financed clinical trials.
    Lachin JM
    Stat Med; 2004 May; 23(10):1519-21. PubMed ID: 15122730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.